| Dr Keith A Hollingsworth, MD | |
|
2405 N Columbus St, Suite 120, Lancaster, OH 43130-8185 | |
| (740) 687-3346 | |
| (740) 689-9736 |
| Full Name | Dr Keith A Hollingsworth |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 36 Years |
| Location | 2405 N Columbus St, Lancaster, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063490647 | NPI | - | NPPES |
| 2022939 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 35-072984 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairfield Medical Center | Lancaster, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| River Valley Orthopaedics And Sports Medicine Inc | 7214827526 | 7 |
News Archive
Sapient Discovery, LLC., a structure-guided drug discovery company, announced today that it has entered into a research collaboration agreement with the Helicon Therapeutics, Inc., a San Diego based pharmaceutical company. Under the terms of the agreement, Sapient Discovery will apply its proprietary structural biology platform and expertise to determine the three-dimensional structures for targets of interest to Helicon Therapeutics, Inc.
A research team led by the Duke-NUS Graduate Medical School in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia, making it possible to develop drugs that may extend the survival of these patients.
Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has accepted for purchase all of the shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. at a purchase price of $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
Contrary to prevailing assumptions, children are more vulnerable to the harmful effects of lead exposure at the age of 6 than they are in early childhood, according to a Cincinnati Children's Hospital Medical Center study to be presented May 4 at the annual meeting of the Pediatric Academic Societies in Honolulu.
› Verified 2 days ago
| Entity Name | River Valley Orthopaedics & Sports Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669450961 PECOS PAC ID: 7214827526 Enrollment ID: O20040319000000 |
News Archive
Sapient Discovery, LLC., a structure-guided drug discovery company, announced today that it has entered into a research collaboration agreement with the Helicon Therapeutics, Inc., a San Diego based pharmaceutical company. Under the terms of the agreement, Sapient Discovery will apply its proprietary structural biology platform and expertise to determine the three-dimensional structures for targets of interest to Helicon Therapeutics, Inc.
A research team led by the Duke-NUS Graduate Medical School in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia, making it possible to develop drugs that may extend the survival of these patients.
Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has accepted for purchase all of the shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. at a purchase price of $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
Contrary to prevailing assumptions, children are more vulnerable to the harmful effects of lead exposure at the age of 6 than they are in early childhood, according to a Cincinnati Children's Hospital Medical Center study to be presented May 4 at the annual meeting of the Pediatric Academic Societies in Honolulu.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith A Hollingsworth, MD 2405 N Columbus St, Suite 120, Lancaster, OH 43130-8185 Ph: (740) 687-3346 | Dr Keith A Hollingsworth, MD 2405 N Columbus St, Suite 120, Lancaster, OH 43130-8185 Ph: (740) 687-3346 |
News Archive
Sapient Discovery, LLC., a structure-guided drug discovery company, announced today that it has entered into a research collaboration agreement with the Helicon Therapeutics, Inc., a San Diego based pharmaceutical company. Under the terms of the agreement, Sapient Discovery will apply its proprietary structural biology platform and expertise to determine the three-dimensional structures for targets of interest to Helicon Therapeutics, Inc.
A research team led by the Duke-NUS Graduate Medical School in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia, making it possible to develop drugs that may extend the survival of these patients.
Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has accepted for purchase all of the shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. at a purchase price of $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
Contrary to prevailing assumptions, children are more vulnerable to the harmful effects of lead exposure at the age of 6 than they are in early childhood, according to a Cincinnati Children's Hospital Medical Center study to be presented May 4 at the annual meeting of the Pediatric Academic Societies in Honolulu.
› Verified 2 days ago
Francis Paul Degenova, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2405 N Columbus St Ste 120, Lancaster, OH 43130 Phone: 740-687-3346 Fax: 740-689-9736 | |
David M. Vaziri, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2405 N Columbus St, Suite 150, Lancaster, OH 43130 Phone: 740-687-3346 Fax: 740-689-9736 | |
Dr. Stephen J Voto, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2682 Kull Road, Lancaster, OH 43130 Phone: 740-687-3394 Fax: 740-687-3333 | |
Dr. Mark M D'onofrio, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2405 N Columbus St, Suite 120, Lancaster, OH 43130 Phone: 740-687-3346 Fax: 740-689-9736 | |
Dr. Steven V Priano, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2405 N Columbus St, Suite 120, Lancaster, OH 43130 Phone: 740-687-3346 Fax: 740-689-9736 | |
Mr. Trevor Roberts Call, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2384 N Memorial Dr, Lancaster, OH 43130 Phone: 740-689-4935 Fax: 740-689-4889 |